Metaceutic ApS: Financial statements 2022
CVR: 40638350
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Metaceutic ApS (CVR 40638350) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -987,282 and a net result of DKK -1,801,730 compared with DKK -4,185,532 the year before. Equity in the 2022 report amounted to DKK 1,267,787. The solvency ratio was 72.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -987,282
- Profit/Loss
- DKK -1,801,730
- Equity
- DKK 1,267,787
- Total Assets
- DKK 1,759,515
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -987 t. | -1.8 mio. | 1.3 mio. | 2 |
| 2021 | - | -2.2 mio. | -4.2 mio. | 2.1 mio. | 4 |
Official annual report
Keep an eye on Metaceutic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Metaceutic ApS has published its annual report for 2021. Gross profit came to DKK -2,188,780, and the net result was DKK -4,185,532.
About Metaceutic ApS
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.